ID   AASS_HUMAN              Reviewed;         926 AA.
AC   Q9UDR5; O95462;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Alpha-aminoadipic semialdehyde synthase, mitochondrial;
DE   AltName: Full=LKR/SDH;
DE   Includes:
DE     RecName: Full=Lysine ketoglutarate reductase;
DE              Short=LKR;
DE              Short=LOR;
DE              EC=1.5.1.8;
DE   Includes:
DE     RecName: Full=Saccharopine dehydrogenase;
DE              Short=SDH;
DE              EC=1.5.1.9;
DE   Flags: Precursor;
GN   Name=AASS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND INVOLVEMENT IN
RP   HYPLYS1.
RX   PubMed=10775527; DOI=10.1086/302919;
RA   Sacksteder K.A., Biery B.J., Morrell J.C., Goodman B.K.,
RA   Geisbrecht B.V., Cox R.P., Gould S.J., Geraghty M.T.;
RT   "Identification of the alpha-aminoadipic semialdehyde synthase gene,
RT   which is defective in familial hyperlysinemia.";
RL   Am. J. Hum. Genet. 66:1736-1743(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Papes F., Kemper E.L., Cord-Neto G., Langone F., Arruda P.;
RT   "Cloning and expression analysis of the LKR/SDH gene in human
RT   tissues.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5]
RP   INVOLVEMENT IN DECRD.
RX   PubMed=24847004; DOI=10.1093/hmg/ddu218;
RA   Houten S.M., Denis S., Te Brinke H., Jongejan A., van Kampen A.H.,
RA   Bradley E.J., Baas F., Hennekam R.C., Millington D.S., Young S.P.,
RA   Frazier D.M., Gucsavas-Calikoglu M., Wanders R.J.;
RT   "Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes
RT   dienoyl-CoA reductase deficiency with hyperlysinemia.";
RL   Hum. Mol. Genet. 23:5009-5016(2014).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Bifunctional enzyme that catalyzes the first two steps
CC       in lysine degradation. The N-terminal and the C-terminal contain
CC       lysine-ketoglutarate reductase and saccharopine dehydrogenase
CC       activity, respectively.
CC   -!- CATALYTIC ACTIVITY: N(6)-(L-1,3-dicarboxypropyl)-L-lysine +
CC       NADP(+) + H(2)O = L-lysine + 2-oxoglutarate + NADPH.
CC   -!- CATALYTIC ACTIVITY: N(6)-(L-1,3-dicarboxypropyl)-L-lysine + NAD(+)
CC       + H(2)O = L-glutamate + (S)-2-amino-6-oxohexanoate + NADH.
CC   -!- PATHWAY: Amino-acid degradation; L-lysine degradation via
CC       saccharopine pathway; glutaryl-CoA from L-lysine: step 1/6.
CC   -!- PATHWAY: Amino-acid degradation; L-lysine degradation via
CC       saccharopine pathway; glutaryl-CoA from L-lysine: step 2/6.
CC   -!- SUBUNIT: Homodimer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in all 16 tissues examined with
CC       highest expression in the liver.
CC   -!- INDUCTION: Induced by starvation. {ECO:0000250}.
CC   -!- DISEASE: Hyperlysinemia, 1 (HYPLYS1) [MIM:238700]: An autosomal
CC       recessive metabolic condition with variable clinical features.
CC       Some patients present with non-specific seizures, hypotonia, or
CC       mildly delayed psychomotor development, and increased serum lysine
CC       and pipecolic acid on laboratory analysis. However, about half of
CC       the probands are reported to be asymptomatic, and hyperlysinemia
CC       is generally considered to be a benign metabolic variant.
CC       {ECO:0000269|PubMed:10775527}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: 2,4-dienoyl-CoA reductase deficiency (DECRD)
CC       [MIM:616034]: A rare, autosomal recessive, inborn error of
CC       polyunsaturated fatty acids and lysine metabolism, resulting in
CC       mitochondrial dysfunction. Affected individuals have a severe
CC       encephalopathy with neurologic and metabolic abnormalities
CC       beginning in early infancy. Laboratory studies show increased
CC       C10:2 carnitine levels and hyperlysinemia.
CC       {ECO:0000269|PubMed:24847004}. Note=The protein represented in
CC       this entry is involved in disease pathogenesis. A selective
CC       decrease in mitochondrial NADP(H) levels due to NADK2 mutations
CC       causes a deficiency of NADPH-dependent mitochondrial enzymes, such
CC       as DECR1 and AASS. {ECO:0000269|PubMed:24847004}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the AlaDH/PNT
CC       family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the saccharopine
CC       dehydrogenase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF229180; AAF44328.1; -; mRNA.
DR   EMBL; AJ007714; CAA07619.2; -; mRNA.
DR   EMBL; AC006020; AAF03526.1; -; Genomic_DNA.
DR   CCDS; CCDS5783.1; -.
DR   RefSeq; NP_005754.2; NM_005763.3.
DR   UniGene; Hs.156738; -.
DR   ProteinModelPortal; Q9UDR5; -.
DR   SMR; Q9UDR5; -.
DR   BioGrid; 115459; 6.
DR   IntAct; Q9UDR5; 2.
DR   MINT; MINT-2820994; -.
DR   STRING; 9606.ENSP00000377040; -.
DR   DrugBank; DB00142; L-Glutamic Acid.
DR   DrugBank; DB04207; N-(5-Amino-5-Carboxypentyl)Glutamic Acid.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB02338; Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate.
DR   iPTMnet; Q9UDR5; -.
DR   PhosphoSitePlus; Q9UDR5; -.
DR   BioMuta; AASS; -.
DR   DMDM; 46396032; -.
DR   EPD; Q9UDR5; -.
DR   MaxQB; Q9UDR5; -.
DR   PaxDb; Q9UDR5; -.
DR   PeptideAtlas; Q9UDR5; -.
DR   PRIDE; Q9UDR5; -.
DR   Ensembl; ENST00000393376; ENSP00000377040; ENSG00000008311.
DR   Ensembl; ENST00000417368; ENSP00000403768; ENSG00000008311.
DR   GeneID; 10157; -.
DR   KEGG; hsa:10157; -.
DR   UCSC; uc003vka.4; human.
DR   CTD; 10157; -.
DR   DisGeNET; 10157; -.
DR   GeneCards; AASS; -.
DR   HGNC; HGNC:17366; AASS.
DR   HPA; HPA020637; -.
DR   HPA; HPA020728; -.
DR   HPA; HPA020734; -.
DR   MalaCards; AASS; -.
DR   MIM; 238700; phenotype.
DR   MIM; 605113; gene.
DR   MIM; 616034; phenotype.
DR   neXtProt; NX_Q9UDR5; -.
DR   OpenTargets; ENSG00000008311; -.
DR   Orphanet; 2203; Hyperlysinemia.
DR   Orphanet; 3124; Saccharopinuria.
DR   PharmGKB; PA24369; -.
DR   eggNOG; KOG0172; Eukaryota.
DR   eggNOG; COG1748; LUCA.
DR   GeneTree; ENSGT00390000013249; -.
DR   HOGENOM; HOG000252920; -.
DR   HOVERGEN; HBG048688; -.
DR   InParanoid; Q9UDR5; -.
DR   KO; K14157; -.
DR   OMA; YGPEEKD; -.
DR   OrthoDB; EOG091G03D7; -.
DR   PhylomeDB; Q9UDR5; -.
DR   TreeFam; TF105728; -.
DR   BioCyc; MetaCyc:HS00244-MONOMER; -.
DR   Reactome; R-HSA-71064; Lysine catabolism.
DR   SABIO-RK; Q9UDR5; -.
DR   UniPathway; UPA00868; UER00835.
DR   UniPathway; UPA00868; UER00836.
DR   ChiTaRS; AASS; human.
DR   GeneWiki; AASS; -.
DR   GenomeRNAi; 10157; -.
DR   PRO; PR:Q9UDR5; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000008311; -.
DR   CleanEx; HS_AASS; -.
DR   ExpressionAtlas; Q9UDR5; baseline and differential.
DR   Genevisible; Q9UDR5; HS.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0047131; F:saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity; EXP:Reactome.
DR   GO; GO:0047130; F:saccharopine dehydrogenase (NADP+, L-lysine-forming) activity; EXP:Reactome.
DR   GO; GO:0033512; P:L-lysine catabolic process to acetyl-CoA via saccharopine; IEA:UniProtKB-UniPathway.
DR   GO; GO:0006554; P:lysine catabolic process; TAS:Reactome.
DR   GO; GO:0051262; P:protein tetramerization; TAS:UniProtKB.
DR   InterPro; IPR007886; AlaDH/PNT_N.
DR   InterPro; IPR007698; AlaDH/PNT_NAD(H)-bd.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR032095; Sacchrp_dh_C.
DR   InterPro; IPR005097; Sacchrp_dh_NADP.
DR   Pfam; PF05222; AlaDh_PNT_N; 1.
DR   Pfam; PF16653; Sacchrp_dh_C; 1.
DR   Pfam; PF03435; Sacchrp_dh_NADP; 1.
DR   SMART; SM01002; AlaDh_PNT_C; 1.
DR   SMART; SM01003; AlaDh_PNT_N; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Complete proteome; Mitochondrion; Multifunctional enzyme;
KW   NAD; NADP; Oxidoreductase; Reference proteome; Transit peptide.
FT   TRANSIT       1     32       Mitochondrion. {ECO:0000250}.
FT   CHAIN        33    926       Alpha-aminoadipic semialdehyde synthase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000001052.
FT   REGION       33    455       Lysine-ketoglutarate reductase.
FT   REGION      477    926       Saccharopine dehydrogenase.
FT   MOD_RES      48     48       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES      56     56       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES      93     93       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES      93     93       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     128    128       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     138    138       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     138    138       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     274    274       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     286    286       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     286    286       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     333    333       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     458    458       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     458    458       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     523    523       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     523    523       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     535    535       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     535    535       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     584    584       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     584    584       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     707    707       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     732    732       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     739    739       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     761    761       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     761    761       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   MOD_RES     780    780       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q99K67}.
FT   CONFLICT    589    589       S -> C (in Ref. 2; CAA07619).
FT                                {ECO:0000305}.
SQ   SEQUENCE   926 AA;  102132 MW;  CB4194014351A18D CRC64;
     MLQVHRTGLG RLGVSLSKGL HHKAVLAVRR EDVNAWERRA PLAPKHIKGI TNLGYKVLIQ
     PSNRRAIHDK DYVKAGGILQ EDISEACLIL GVKRPPEEKL MSRKTYAFFS HTIKAQEANM
     GLLDEILKQE IRLIDYEKMV DHRGVRVVAF GQWAGVAGMI NILHGMGLRL LALGHHTPFM
     HIGMAHNYRN SSQAVQAVRD AGYEISLGLM PKSIGPLTFV FTGTGNVSKG AQAIFNELPC
     EYVEPHELKE VSQTGDLRKV YGTVLSRHHH LVRKTDAVYD PAEYDKHPER YISRFNTDIA
     PYTTCLINGI YWEQNTPRLL TRQDAQSLLA PGKFSPAGVE GCPALPHKLV AICDISADTG
     GSIEFMTECT TIEHPFCMYD ADQHIIHDSV EGSGILMCSI DNLPAQLPIE ATECFGDMLY
     PYVEEMILSD ATQPLESQNF SPVVRDAVIT SNGTLPDKYK YIQTLRESRE RAQSLSMGTR
     RKVLVLGSGY ISEPVLEYLS RDGNIEITVG SDMKNQIEQL GKKYNINPVS MDICKQEEKL
     GFLVAKQDLV ISLLPYVLHP LVAKACITNK VNMVTASYIT PALKELEKSV EDAGITIIGE
     LGLDPGLDHM LAMETIDKAK EVGATIESYI SYCGGLPAPE HSNNPLRYKF SWSPVGVLMN
     VMQSATYLLD GKVVNVAGGI SFLDAVTSMD FFPGLNLEGY PNRDSTKYAE IYGISSAHTL
     LRGTLRYKGY MKALNGFVKL GLINREALPA FRPEANPLTW KQLLCDLVGI SPSSEHDVLK
     EAVLKKLGGD NTQLEAAEWL GLLGDEQVPQ AESILDALSK HLVMKLSYGP EEKDMIVMRD
     SFGIRHPSGH LEHKTIDLVA YGDINGFSAM AKTVGLPTAM AAKMLLDGEI GAKGLMGPFS
     KEIYGPILER IKAEGIIYTT QSTIKP
//
